Perspectives on the interface of drug delivery and tissue engineering
Controlled drug delivery of bioactive molecules continues to be an essential component of engineering strategies for tissue defect repair. This article surveys the current challenges associated with trying to regenerate complex tissues utilizing drug delivery and gives perspectives on the developmen...
Gespeichert in:
| Veröffentlicht in: | Advanced drug delivery reviews 2013-01, Vol.65 (1), p.89-92 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 92 |
|---|---|
| container_issue | 1 |
| container_start_page | 89 |
| container_title | Advanced drug delivery reviews |
| container_volume | 65 |
| creator | Ekenseair, Adam K. Kasper, F. Kurtis Mikos, Antonios G. |
| description | Controlled drug delivery of bioactive molecules continues to be an essential component of engineering strategies for tissue defect repair. This article surveys the current challenges associated with trying to regenerate complex tissues utilizing drug delivery and gives perspectives on the development of translational tissue engineering therapies which promote spatiotemporal cell-signaling cascades to maximize the rate and quality of repair.
[Display omitted] |
| doi_str_mv | 10.1016/j.addr.2012.08.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3548991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169409X12002955</els_id><sourcerecordid>1315624109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-dc71e888f850ccfd6aa3ec6b168f203b2d612a5be2efe5a47c0ecc303bf886db3</originalsourceid><addsrcrecordid>eNqFkUFLHDEUgEOp1NX2D_RQcuxlxpfMTCYDRZDFqiDoQaG3kEle1iyzmW0ys-C_b5a10l70lMP73keSj5CvDEoGTJytS21tLDkwXoIsgbUfyILJlheSd_VHsshQV9TQ_TomJymtIYOtgE_kmFcA0NbVglzeY0xbNJPfYaJjoNMTUh8mjE4bpKOjNs4ranHIQHymOlg6-ZRmpBhWPiBGH1afyZHTQ8IvL-cpefx5-bC8Lm7vrm6WF7eFaZp6KqxpGUopnWzAGGeF1hUa0TMhHYeq51YwrpseOTpsdN0aQGOqPHFSCttXp-T84N3O_QatwTBFPaht9Bsdn9Wovfp_EvyTWo07VTW17DqWBd9fBHH8PWOa1MYng8OgA45zUqxijeA1g-59lMtacJa1GeUH1MQxpYju9UYM1D6VWqt9KrVPpUCqnCovffv3La8rf9tk4McBwPyjO49RJeMxGLQ-5mDKjv4t_x_dfacc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1284621899</pqid></control><display><type>article</type><title>Perspectives on the interface of drug delivery and tissue engineering</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ekenseair, Adam K. ; Kasper, F. Kurtis ; Mikos, Antonios G.</creator><creatorcontrib>Ekenseair, Adam K. ; Kasper, F. Kurtis ; Mikos, Antonios G.</creatorcontrib><description>Controlled drug delivery of bioactive molecules continues to be an essential component of engineering strategies for tissue defect repair. This article surveys the current challenges associated with trying to regenerate complex tissues utilizing drug delivery and gives perspectives on the development of translational tissue engineering therapies which promote spatiotemporal cell-signaling cascades to maximize the rate and quality of repair.
[Display omitted]</description><identifier>ISSN: 0169-409X</identifier><identifier>EISSN: 1872-8294</identifier><identifier>DOI: 10.1016/j.addr.2012.08.017</identifier><identifier>PMID: 23000743</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biological Products - administration & dosage ; Biological Products - chemistry ; Drug Delivery Systems - methods ; Extracellular matrix ; Humans ; Scaffolds ; Spatiotemporal control ; Tissue Engineering - methods ; Tissue regeneration ; Translational medicine</subject><ispartof>Advanced drug delivery reviews, 2013-01, Vol.65 (1), p.89-92</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><rights>2012 Elsevier B.V. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-dc71e888f850ccfd6aa3ec6b168f203b2d612a5be2efe5a47c0ecc303bf886db3</citedby><cites>FETCH-LOGICAL-c554t-dc71e888f850ccfd6aa3ec6b168f203b2d612a5be2efe5a47c0ecc303bf886db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0169409X12002955$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23000743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ekenseair, Adam K.</creatorcontrib><creatorcontrib>Kasper, F. Kurtis</creatorcontrib><creatorcontrib>Mikos, Antonios G.</creatorcontrib><title>Perspectives on the interface of drug delivery and tissue engineering</title><title>Advanced drug delivery reviews</title><addtitle>Adv Drug Deliv Rev</addtitle><description>Controlled drug delivery of bioactive molecules continues to be an essential component of engineering strategies for tissue defect repair. This article surveys the current challenges associated with trying to regenerate complex tissues utilizing drug delivery and gives perspectives on the development of translational tissue engineering therapies which promote spatiotemporal cell-signaling cascades to maximize the rate and quality of repair.
[Display omitted]</description><subject>Biological Products - administration & dosage</subject><subject>Biological Products - chemistry</subject><subject>Drug Delivery Systems - methods</subject><subject>Extracellular matrix</subject><subject>Humans</subject><subject>Scaffolds</subject><subject>Spatiotemporal control</subject><subject>Tissue Engineering - methods</subject><subject>Tissue regeneration</subject><subject>Translational medicine</subject><issn>0169-409X</issn><issn>1872-8294</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFLHDEUgEOp1NX2D_RQcuxlxpfMTCYDRZDFqiDoQaG3kEle1iyzmW0ys-C_b5a10l70lMP73keSj5CvDEoGTJytS21tLDkwXoIsgbUfyILJlheSd_VHsshQV9TQ_TomJymtIYOtgE_kmFcA0NbVglzeY0xbNJPfYaJjoNMTUh8mjE4bpKOjNs4ranHIQHymOlg6-ZRmpBhWPiBGH1afyZHTQ8IvL-cpefx5-bC8Lm7vrm6WF7eFaZp6KqxpGUopnWzAGGeF1hUa0TMhHYeq51YwrpseOTpsdN0aQGOqPHFSCttXp-T84N3O_QatwTBFPaht9Bsdn9Wovfp_EvyTWo07VTW17DqWBd9fBHH8PWOa1MYng8OgA45zUqxijeA1g-59lMtacJa1GeUH1MQxpYju9UYM1D6VWqt9KrVPpUCqnCovffv3La8rf9tk4McBwPyjO49RJeMxGLQ-5mDKjv4t_x_dfacc</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Ekenseair, Adam K.</creator><creator>Kasper, F. Kurtis</creator><creator>Mikos, Antonios G.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Perspectives on the interface of drug delivery and tissue engineering</title><author>Ekenseair, Adam K. ; Kasper, F. Kurtis ; Mikos, Antonios G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-dc71e888f850ccfd6aa3ec6b168f203b2d612a5be2efe5a47c0ecc303bf886db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological Products - administration & dosage</topic><topic>Biological Products - chemistry</topic><topic>Drug Delivery Systems - methods</topic><topic>Extracellular matrix</topic><topic>Humans</topic><topic>Scaffolds</topic><topic>Spatiotemporal control</topic><topic>Tissue Engineering - methods</topic><topic>Tissue regeneration</topic><topic>Translational medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ekenseair, Adam K.</creatorcontrib><creatorcontrib>Kasper, F. Kurtis</creatorcontrib><creatorcontrib>Mikos, Antonios G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advanced drug delivery reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ekenseair, Adam K.</au><au>Kasper, F. Kurtis</au><au>Mikos, Antonios G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perspectives on the interface of drug delivery and tissue engineering</atitle><jtitle>Advanced drug delivery reviews</jtitle><addtitle>Adv Drug Deliv Rev</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>65</volume><issue>1</issue><spage>89</spage><epage>92</epage><pages>89-92</pages><issn>0169-409X</issn><eissn>1872-8294</eissn><abstract>Controlled drug delivery of bioactive molecules continues to be an essential component of engineering strategies for tissue defect repair. This article surveys the current challenges associated with trying to regenerate complex tissues utilizing drug delivery and gives perspectives on the development of translational tissue engineering therapies which promote spatiotemporal cell-signaling cascades to maximize the rate and quality of repair.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23000743</pmid><doi>10.1016/j.addr.2012.08.017</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0169-409X |
| ispartof | Advanced drug delivery reviews, 2013-01, Vol.65 (1), p.89-92 |
| issn | 0169-409X 1872-8294 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3548991 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Biological Products - administration & dosage Biological Products - chemistry Drug Delivery Systems - methods Extracellular matrix Humans Scaffolds Spatiotemporal control Tissue Engineering - methods Tissue regeneration Translational medicine |
| title | Perspectives on the interface of drug delivery and tissue engineering |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perspectives%20on%20the%20interface%20of%20drug%20delivery%20and%20tissue%20engineering&rft.jtitle=Advanced%20drug%20delivery%20reviews&rft.au=Ekenseair,%20Adam%20K.&rft.date=2013-01-01&rft.volume=65&rft.issue=1&rft.spage=89&rft.epage=92&rft.pages=89-92&rft.issn=0169-409X&rft.eissn=1872-8294&rft_id=info:doi/10.1016/j.addr.2012.08.017&rft_dat=%3Cproquest_pubme%3E1315624109%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1284621899&rft_id=info:pmid/23000743&rft_els_id=S0169409X12002955&rfr_iscdi=true |